Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial

Documenti analoghi

• Letter: Over‐the‐scope clips in patients at high risk of re‐bleeding following upper gastrointestinal tract bleeding—The magic bullet for everyone?
  di: Gabriel Allo, et al.
  Pubblicazione: (2024)
• Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial
  di: Yu Yang, et al.
  Pubblicazione: (2024)
• Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
  di: Nauzer Forbes, et al.
  Pubblicazione: (2024)
• Letter: Post‐endoscopic management after upper gastrointestinal bleeding—Replenishment of iron loss
  di: Palle Bager, et al.
  Pubblicazione: (2024)
• Letter: Reflections on the role of over‐the‐scope clips in high‐risk upper gastrointestinal bleeding
  di: Yajie Wang, et al.
  Pubblicazione: (2024)